6 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $7M | -$3M | 43.9% | -36.3% | -$3M | — | $345144 |
| 2024 | $4M | -$15M | 19.0% | -432.2% | -$2M | — | $237605 |
| 2023 | $4M | -$10M | 22.7% | -106.9% | — | — | $189005 |
| 2022 | $4M | -$25M | 23.1% | -324.6% | -$2M | — | $784485 |
| 2022 | — | -$2M | — | — | — | — | — |
| 2021 | $5M | $864829 | 27.4% | -12.3% | $442819 | — | $189996 |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '23 | $2M | -$2M | 23.8% | -116.4% | — | — | $800000 |
| Oct '22 | — | $201012 | — | — | — | — | — |
| Jul '22 | — | -$1M | — | — | — | — | — |
| Apr '22 | — | -$472989 | — | — | — | — | — |
| Mar '22 | $3M | $222585 | 47.7% | 2.8% | — | — | — |
| Jan '22 | — | -$224890 | — | — | — | — | — |
| Oct '21 | — | -$45587 | — | — | — | — | — |
| Jul '21 | — | -$528 | — | — | — | — | — |
| Apr '21 | — | -$7849 | — | — | — | — | — |
How the market has priced EUDA against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, EUDA Health Holdings Ltd's revenue has grown 10.6% per year. These are computed facts, not advice.
As of FY2025, EUDA Health Holdings Ltd reported — of total debt against $345144 of cash; operating income covered interest expense -10.8×.
In FY2025, gross margin was 43.9%, operating margin -36.3%, and net margin -40.7%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.